Anti-cancer treatment within two weeks serves as a risk factor for clinical outcomes among cancer patients with COVID-19

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has resulted in infections among patients with cancer. Our study aimed to investigate the potential adverse impact of anti-cancer treatments within 2 weeks of COVID-19 infection on clinical outcomes in patients with cancer. METHODS: This r...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jia-Xin, Liu, Bo, Cong, Xiao-Feng, Guan, Yan-Jie, Zhang, Yi-Qun, Song, Wei, Li, Zhi, Liu, Zi-Ling, Wang, Nan-Ya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478212/
https://www.ncbi.nlm.nih.gov/pubmed/37675234
http://dx.doi.org/10.3389/fonc.2023.1193082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478212/
https://www.ncbi.nlm.nih.gov/pubmed/37675234
http://dx.doi.org/10.3389/fonc.2023.1193082

Ejemplares similares